Collegium Pharmaceutical Inc. (COLL)
NASDAQ · Healthcare
Collegium Pharmaceutical Inc. Net Income 2016–2025
Collegium Pharmaceutical Inc. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Collegium Pharmaceutical Inc. net income for the quarter ending March 31, 2026 was 14.5 M, a 499.75% increase year-over-year.
- Collegium Pharmaceutical Inc. net income for the twelve months ending March 31, 2026 was 60.4 M, a 21.85% decrease year-over-year.
- Collegium Pharmaceutical Inc. annual net income for 2025 was 62.9 M, a 9.13% decrease from 2024.
- Collegium Pharmaceutical Inc. annual net income for 2024 was 69.2 M, a 43.68% increase from 2023.
- Collegium Pharmaceutical Inc. annual net income for 2023 was 48.2 M, a 292.60% decrease from 2022.
- Collegium Pharmaceutical Inc. annual net income for 2022 was -25.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Collegium Pharmaceutical Inc. Net Income — FAQ
Collegium Pharmaceutical Inc. (COLL) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Collegium Pharmaceutical Inc.'s net income?
Collegium Pharmaceutical Inc. (COLL) reported net income of $63M for fiscal 2025.
Where can I see COLL's net income history?
The chart and table above show Collegium Pharmaceutical Inc.'s net income by year and by quarter, including the growth rate.